Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration

Pharmacotherapy

Volumn 18, Issue 1, 1998, Pages 1-8

  Higa, Gerald M ^a   DeVore, Russell F ^a   Auber, Miklos L ^a   Lynch, Joseph P ^a   Landreth, Kenneth S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MESNA; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GRANULOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; OUTCOMES RESEARCH;

ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; NEUTROPHILS; PROSPECTIVE STUDIES;

EID: 0031975740     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bodey GP, Buckley M, Sathe YS, Freireich EF. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64: 328-40.
2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328: 1323-32.
3. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-70.
4. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986;232:61-70.
5. Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 1987;236:1229-37.
6. Bronchud MH, Howell A, Crother D, Hopwood P, Souza L, Dexter TM. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 1989;60:121-5.
7. Gabrilove JL, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
8. Yoshida T, Nakamura S, Ohtake S, et al. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 1990;66:1904-9.
9. Hartman LC, Tschetter LK, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med 1997;336:1776-80.
10. Pui CH, Boyett JM, Hughes WT, et al. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 1997;336:1781-7.
11. ASCO Ad Hoc Colony-Stimulating Factor Guideline Expert Panel. American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1994;12:2471-2508.
12. ASCO Ad Hoc Colony-Stimulating Factor Guideline Expert Panel. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1996;14:1957-60.
13. Higa GM, DeVore RF. Optimizing the use of G-CSF based on the post-chemotherapy absolute neutrophil count (ANC) [abstr]. Proc Am Soc Clin Oncol 1994;13:1466.
14. Namiki M, Hara H. Enhancement of colony-forming activity of granulocyte-macrophage colony-stimulating factor by monocytes in vitro. Blood 1989;74:918-24.
15. Haas R, Witt B, Mohle R, et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995;85:3754-61.
16. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colonystimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988;72:2074-81.